News

3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Eli Lilly is grabbing the lead in the fast-growing diabetes drug market. Eli Lilly (NYSE: LLY) has been on fire over the past ...
Exclusive-New Data Show Most US Patients Now Stay on Wegovy, Zepbound After a Year
Sixty-three percent of patients starting on Novo Nordisk's Wegovy or Eli Lilly's Zepbound during the first quarter of 2024 ...